Increased inflammation, endoplasmic reticulum stress and oxidative stress in endothelial and macrophage cells exacerbate atherosclerosis in ApoCIII transgenic mice

被引:24
作者
Han Yingchun [1 ,2 ]
Ma Yahong [3 ]
Wen Jiangping [4 ]
He Xiaokui [4 ]
Zhang Xiaohong [4 ]
机构
[1] Capital Med Univ, Beijing Anzhen Hosp, Beijing 100029, Peoples R China
[2] Beijing Inst Heart Lung & Blood Vessel Dis, Beijing 100029, Peoples R China
[3] Beijing Puren Hosp, Dept Endocrinol, Beijing 100062, Peoples R China
[4] Capital Med Univ, Beijing Tongren Hosp, Dept Lab Med, Beijing 100730, Peoples R China
关键词
Apolipoprotein CIII; Triglyceride-rich lipoprotein; Endothelial cells; Macrophages; Inflammation; Endoplasmic reticulum stress; Oxidative stress; TRIGLYCERIDE-RICH LIPOPROTEINS; LOW-DENSITY-LIPOPROTEIN; OF-FUNCTION MUTATIONS; APOLIPOPROTEIN-CIII; NONFASTING TRIGLYCERIDES; MONOCYTIC CELLS; HEART-DISEASE; RISK; ATHEROGENESIS; CHOLESTEROL;
D O I
10.1186/s12944-018-0867-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Overexpression of apolipoprotein CIII (ApoCIII) leads to hypertriglyceridemia (HTG) which promotes atherosclerosis development. However, it remains unclear whether ApoCIII affects the atherosclerosis alone by promoting the inflammation and endoplasmic reticulum (ER) stress, or in combination with HTG. Methods: Transgenic (ApoCIIItg) mouse models were used to investigate the atherogenic role of ApoCIII. Since endothelial cells and macrophages play crucial roles in atherosclerosis, we examined whether triglyceride-rich lipoproteins (TRLs), the major lipoproteins, in plasma of ApoCIIItg mice affect inflammation and ER stress levels in these cells. To further investigate the role of ApoCIII and triglyceride, we incubated HUVECs cells and peritoneal macrophages with TRLs with or without ApoCIII. Results: Increased inflammation and ER stress were found in the aorta of ApoCIIItg mice. TRLs increased ER stress and oxidative stress in HUVECs and macrophages in a dose dependent. Moreover, TRLs together with ApoCIII could induce a higher inflammation level than TRLs alone in these cells. Conclusions: Both TRLs and ApoCIII contribute to the progression of atherosclerosis, and the modulation of TRLs and ApoCIII may represent a novel therapeutic approach against HTG induced atherosclerosis.
引用
收藏
页数:9
相关论文
共 26 条
[1]   Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women [J].
Bansal, Sandeep ;
Buring, Julie E. ;
Rifai, Nader ;
Mora, Samia ;
Sacks, Frank M. ;
Ridker, Paul M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (03) :309-316
[2]   Postprandial lipoproteins and the molecular regulation of vascular homeostasis [J].
Botham, Kathleen M. ;
Wheeler-Jones, Caroline P. D. .
PROGRESS IN LIPID RESEARCH, 2013, 52 (04) :446-464
[3]   Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease [J].
Crosby, Jacy ;
Peloso, Gina M. ;
Auer, Paul L. ;
Crosslin, David R. ;
Stitziel, Nathan O. ;
Lange, Leslie A. ;
Lu, Yingchang ;
Tang, Zheng-zheng ;
Zhang, He ;
Hindy, George ;
Masca, Nicholas ;
Stirrups, Kathleen ;
Kanoni, Stavroula ;
Do, Ron ;
Jun, Goo ;
Hu, Youna ;
Kang, Hyun Min ;
Xue, Chenyi ;
Goel, Anuj ;
Farrall, Martin ;
Duga, Stefano ;
Merlini, Pier Angelica ;
Asselta, Rosanna ;
Girelli, Domenico ;
Olivieri, Oliviero ;
Martinelli, Nicola ;
Yin, Wu ;
Reilly, Dermot ;
Speliotes, Elizabeth ;
Fox, Caroline S. ;
Hveem, Kristian ;
Holmen, Oddgeir L. ;
Nikpay, Majid ;
Farlow, Deborah N. ;
Assimes, Themistocles L. ;
Franceschini, Nora ;
Robinson, Jennifer ;
North, Kari E. ;
Martin, Lisa W. ;
DePristo, Mark ;
Gupta, Namrata ;
Escher, Stefan A. ;
Jansson, Jan-Hakan ;
Van Zuydam, Natalie ;
Palmer, Colin N. A. ;
Wareham, Nicholas ;
Koch, Werner ;
Meitinger, Thomas ;
Peters, Annette ;
Lieb, Wolfgang .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (01) :22-31
[4]   Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia [J].
Eriksson, P ;
Nilsson, L ;
Karpe, F ;
Hamsten, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (01) :20-26
[5]   Targeting APOC3 in the Familial Chylomicronemia Syndrome [J].
Gaudet, Daniel ;
Brisson, Diane ;
Tremblay, Karine ;
Alexander, Veronica J. ;
Singleton, Walter ;
Hughes, Steven G. ;
Geary, Richard S. ;
Baker, Brenda F. ;
Graham, Mark J. ;
Crooke, Rosanne M. ;
Witztum, Joseph L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (23) :2200-2206
[6]   APOLIPOPROTEIN-B METABOLISM IN SUBJECTS WITH DEFICIENCY OF APOLIPOPROTEINS-CIII AND APOLIPOPROTEIN-A-I - EVIDENCE THAT APOLIPOPROTEIN-CIII INHIBITS CATABOLISM OF TRIGLYCERIDE-RICH LIPOPROTEINS BY LIPOPROTEIN-LIPASE INVIVO [J].
GINSBERG, HN ;
LE, NA ;
GOLDBERG, IJ ;
GIBSON, JC ;
RUBINSTEIN, A ;
WANGIVERSON, P ;
NORUM, R ;
BROWN, WV .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (05) :1287-1295
[7]   ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors [J].
Gordts, Philip L. S. M. ;
Nock, Ryan ;
Son, Ni-Huiping ;
Ramms, Bastian ;
Lew, Irene ;
Gonzales, Jon C. ;
Thacker, Bryan E. ;
Basu, Debapriya ;
Lee, Richard G. ;
Mullick, Adam E. ;
Graham, Mark J. ;
Goldberg, Ira J. ;
Crooke, Rosanne M. ;
Witztum, Joseph L. ;
Esko, Jeffrey D. .
JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (08) :2855-2866
[8]   Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans [J].
Graham, Mark J. ;
Lee, Richard G. ;
Bell, Thomas A., III ;
Fu, Wuxia ;
Mullick, Adam E. ;
Alexander, Veronica J. ;
Singleton, Walter ;
Viney, Nick ;
Geary, Richard ;
Su, John ;
Baker, Brenda F. ;
Burkey, Jennifer ;
Crooke, Stanley T. ;
Crooke, Rosanne M. .
CIRCULATION RESEARCH, 2013, 112 (11) :1479-U221
[9]   Reduced high density lipoprotein cholesterol in severe hypertriglyceridemic ApoCIII transgenic mice via lowered hepatic ApoAI synthesis [J].
Han, Yingchun ;
Qi, Rong ;
Liu, George .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 462 (04) :420-425
[10]   TRIGLYCERIDE-RICH AND CHOLESTEROL-RICH LIPOPROTEINS HAVE A DIFFERENTIAL EFFECT ON MILD/MODERATE AND SEVERE LESION PROGRESSION AS ASSESSED BY QUANTITATIVE CORONARY ANGIOGRAPHY IN A CONTROLLED TRIAL OF LOVASTATIN [J].
HODIS, HN ;
MACK, WJ ;
AZEN, SP ;
ALAUPOVIC, P ;
POGODA, JM ;
LABREE, L ;
HEMPHILL, LC ;
KRAMSCH, DM ;
BLANKENHORN, DH .
CIRCULATION, 1994, 90 (01) :42-49